Expertise & passion

Pascal is the founder and CEO of Genoskin. Before launching the company 11 years ago, Pascal had acquired over 15 years of experience in research on the development and characterization of pathological skin models. He holds a PhD in Pathophysiology from the University of Toulouse, France. He also holds Master’s Degree in Management from Toulouse Business School.

Back in 2009, as a researcher in skin biology and rare skin diseases, Pascal realized that animals are not replicating human biology effectively enough. He also realized that thousands of human skin samples discarded from plastic surgeries every year, could be used to help researchers to discover new drugs and avoid animal experimentation.

Pascal saw the opportunity to use an abundantly available resource without having to harm animals and without having to support all the costs associated with animal experimentation. Discarded human skin samples are precious, because they’re human, more reliable and can help researchers to reduce development cost and time to get drugs to market by offering access to reliable human data.

Dr Gaudenzio completed his PhD in 2012 at the University of Toulouse, France, and holds a doctorate in immunology. Following his post-doctorate in the Department of Pathology at Stanford University (CA, USA), he now heads a large Inserm cross-disciplinary research group, which was awarded a Starting Grant from the European Research Council (ERC) in 2018. His work has contributed substantially to identifying molecular and cellular targets involved in allergic and non-allergic inflammation and to the development of new data analysis processes to study preclinical models and clinical samples from patients. In 2021, Dr Gaudenzio received the prestigious ACTERIA Early Career Research Prize in Allergology awarded every two years by the European Federation of Immunological Societies (EFIS) and the award of physiology and medicine from the French Academy of Sciences in Lyon, France.

Dr Gaudenzio’s work has been published in prestigious scientific journals such as Nature Immunology, Nature Medicine, Cell, Science, Nature Communications and others. He is a member of the European Academy of Allergy and Clinical Immunology (EAACI) and the French Society for Immunology (SFI).

Anna joined Genoskin in 2022 to lead our global sales and business development teams, bringing with her 20 years of business development and leadership experience in the Biotech industry and non-clinical CRO field. Anna began her career in academic research at Thomas Jefferson University, resulting in several publications. Subsequently transitioning into the private sector, Anna held roles of increasing commercial scope and responsibility for major biotechnology companies including ThermoFisher Scientific, Qiagen and EMD Millipore. Most recently, Anna was Head of US Sales and Technical Support (Catalog Products) at Genscript. She holds a Bachelor of Science Degree in Biochemistry and a Master’s Degree in Microbiology. Anna’s leadership ensures that the Genoskin sales team provides our clients with thoughtful and tailored guidance, identifying the leading edge of Genoskin products in order to best support their specific research needs.